ZMapp's 'moment-of-truth' efficacy trial starts

Researchers are finally able to test whether the experimental drug ZMapp earned the attention it's been getting since this past fall or whether it's all hype – the drug's moment of truth.

More from Immunological

More from Therapy Areas